Inspec

Inspec FCF per Share

The Free Cash Flow per Share of Inspec (6656.T) as of Oct 21, 2026 is -143.10 JPY. In the previous year, Free Cash Flow per Share was 114.46 JPY — a change of -225.02% (lower).

FCF per Share

-143.10JPY

YoY

-225.02%

Last updated:

Free Cash Flow per Share of Inspec is 2026 -143.10 JPY. Free Cash Flow per Share of Inspec was 2025 114.46 JPY. It decreases by -225.02% lower compared to the previous year.

The Inspec FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
132.45 JPY
Jan 1, 2020
-100.02 JPY
Jan 1, 2021
-76.16 JPY
Jan 1, 2022
-119.72 JPY
Jan 1, 2023
-180.37 JPY
Jan 1, 2024
4.85 JPY
Jan 1, 2025
114.46 JPY
Jan 1, 2026
-143.10 JPY
The Inspec FCF per Share history
YEARFCF per ShareYoY
-143.10JPY-225.02%
114.46JPY+2,260.78%
4.85JPY-102.69%
-180.37JPY+50.67%
-119.72JPY+57.18%
-76.16JPY-23.86%
-100.02JPY-175.52%
132.45JPY-182.72%
-160.13JPY-297.32%
81.15JPY+121.95%
36.56JPY-181.36%
-44.94JPY-44.93%
-81.61JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Free Cash Flow per Share of Inspec is -143.10 JPY in 2026.

Free Cash Flow per Share of Inspec changed from 114.46 JPY to -143.10 JPY, representing a -225.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Inspec since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Inspec

All Key Metrics — Inspec